Literature DB >> 11450260

Interactions of lipoproteins with proteoglycans.

K J Williams1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11450260     DOI： 10.1385/1-59259-209-0:457

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  9 in total

1.  Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins.

Authors:  Keyang Chen; Ming-Lin Liu; Lana Schaffer; Mingzhen Li; Guenther Boden; Xiangdong Wu; Kevin Jon Williams
Journal:  Hepatology       Date:  2010-11-03       Impact factor: 17.425

2.  Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.

Authors:  Kristin I Stanford; Lianchun Wang; Jan Castagnola; Danyin Song; Joseph R Bishop; Jillian R Brown; Roger Lawrence; Xaiomei Bai; Hiroko Habuchi; Masakazu Tanaka; Wellington V Cardoso; Koji Kimata; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

3.  Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor.

Authors:  Keyang Chen; Kevin Jon Williams
Journal:  J Biol Chem       Date:  2013-03-22       Impact factor: 5.157

4.  Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.

Authors:  Keyang Chen; Qingsi Wu; Kongwang Hu; Chengwei Yang; Xiangdong Wu; Peter Cheung; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

5.  Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.

Authors:  Yiping Deng; Erin M Foley; Jon C Gonzales; Philip L Gordts; Yulin Li; Jeffrey D Esko
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

Review 6.  Unlocking the secrets of syndecans: transgenic organisms as a potential key.

Authors:  Robert Bellin; Ishan Capila; John Lincecum; Pyong Woo Park; Ofer Reizes; Merton R Bernfield
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 7.  Pathology of coronary atherosclerosis and thrombosis.

Authors:  Fumiyuki Otsuka; Satoshi Yasuda; Teruo Noguchi; Hatsue Ishibashi-Ueda
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

8.  Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.

Authors:  Kristin I Stanford; Joseph R Bishop; Erin M Foley; Jon C Gonzales; Ingrid R Niesman; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

Review 9.  Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.

Authors:  Kazuyuki Yahagi; Frank D Kolodgie; Fumiyuki Otsuka; Aloke V Finn; Harry R Davis; Michael Joner; Renu Virmani
Journal:  Nat Rev Cardiol       Date:  2015-10-27       Impact factor: 32.419
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.